Sign In

Also in this Section

The Liver Fibrosis SIG is an interactive group of investigators focusing on the pathogenesis, diagnosis, development of therapeutics for liver fibrosis and outcomes. The goals of our SIG are to broaden our knowledge of the disease and to foster collaborations in basic and translational / clinical studies of liver fibrosis. The Liver Fibrosis SIG sponsors Programs at the AASLD Annual Meeting, identifies emerging topics in fibrosis research and develops educational webinar programs.

SIG Leadership

  • Frank A Anania, MD, FAASLD, FACP, AGAF
    Chair
  • Meena B Bansal, MD
    Vice-Chair
  • Yury Popov, MD, PhD
    Secretary
  • David Brigstock, PhD, FAASLD
    Steering Committee
  • Robert F Schwabe, MD
    Steering Committee
  • Li Wang, PhD, FAASLD
    Steering Committee
  • Bette Anne Preston
    Staff Liaison